4Photo© hindustantimes.comWHO approves first Mpox vaccine to boost disease control in Africa
, 6 news, 2 views
In its effort to control the Mpox outbreak in Africa, the World Health Organization (WHO) has approved Bavarian Nordic's vaccine, known as Jynneos in the United States. It is also reviewing another vaccine, LC16, made by Japan's KM Biologics.
A patient showing his hand with a sore caused by an infection of the monkeypox virus, in the isolation area for monkeypox patients at the Arzobispo Loayza hospital, in Lima, Peru. (Photo by Ernesto BENAVIDES / AFP)
This approval, called prequalification, allows United Nation agencies to purchase the vaccine and coordinate donations. Gavi, the Vaccine Alliance, which helps fund vaccines for low-income countries, has up to $500 million available for mpox vaccines.
“ This first pre-qualification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,
Tedros Adhanom Ghebreyesus,
WHO grants first mpox vaccine approval to ramp up response to disease…
“ This first (authorization) of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future,
Tedros Adhanom Ghebreyesus,
WHO Grants First Mpox Vaccine Approval Amid Surging Cases In Africa